Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings
Open accessAbstract
Context: Early treatment of primary congenital hypothyroidism (CH) prevents irreversible brain damage. Contrary to primary CH, outcome studies on central CH are scarce. Most patients with central CH have multiple pituitary hormone deficiencies (MPHD); these patients are also at risk for neonatal hypoglycemia. Objective: To assess cognitive and motor outcome in patients with early-treated central CH detected by the Dutch neonatal screening. Methods: In this cross-sectional study, primary outcome full-scale intelligence quotient (FSIQ) was measured in patients with MPHD and patients with isolated central CH born between January 1, 1995, and January 1, 2015, with siblings as controls. Secondary outcomes were intelligence test subscales and motor function. Linear mixed models were used to compare both patient groups and siblings, followed by post hoc tests in case of significant differences. Results: Eighty-seven patients (52 MPHD; 35 isolated central CH) and 52 siblings were included. Estimated marginal means for FSIQ were 90.7 (95% CI 86.4-95.0) in patients with MPHD and 98.2 (95% CI 93.0-103.5) in patients with isolated central CH. While patients with MPHD scored lower FSIQs than siblings (mean difference –7.9 points, 95% CI –13.4 to –2.5; P = .002), patients with isolated central CH did not. Processing speed was lower in both patient groups than in siblings (mean differences –10.5 and –10.3 points). Motor difficulties occurred significantly more often in patients (33%) versus siblings (5%; P = .004). Conclusion: In early-treated central CH, FSIQ is comparable with siblings in patients with isolated central CH, while patients with MPHD have a significantly lower FSIQ. This may be explained by disease-specific consequences of MPHD, such as neonatal hypoglycemia and more severe hypothyroidism.
AI snapshot
Written from the paper’s full text.
TL;DR
In this Dutch nationwide cross-sectional cohort, early-treated isolated central congenital hypothyroidism was associated with normal full-scale IQ compared with siblings, whereas patients with multiple pituitary hormone deficiencies had significantly lower FSIQ. Both patient groups showed lower processing speed and more motor difficulties than siblings.
Key findings
- Among 87 patients (52 MPHD; 35 isolated central CH) and 52 siblings, estimated marginal mean FSIQ was 90.7 (95% CI 86.4–95.0) in MPHD, 98.2 (95% CI 93.0–103.5) in isolated central CH, and 98.6 (95% CI 94.5–102.8) in siblings. MPHD patients scored 7.9 points lower than siblings (95% CI –13.4 to –2.5; P = .002), while isolated central CH patients did not differ significantly from siblings.
- Processing speed was lower in both patient groups than in siblings, with mean differences of –10.5 points for MPHD and –10.3 points for isolated central CH.
- Motor difficulties on the MABC-2 checklist occurred in 33% of patients versus 5% of siblings (P = .004); delayed motor development requiring physical therapy was present in 34% of patients versus 19% of siblings (P = .03).
- An FSIQ <70 was found in 8 patients (9%) and no sibling controls (P = .04).
Methods
- Cross-sectional study of patients with central CH detected by Dutch neonatal screening, born January 1, 1995, to January 1, 2015; patients were recruited through treating physicians, and each included patient had an unaffected sibling control where available.
- Cognitive assessment used age-appropriate Dutch Wechsler scales (WPPSI-III-NL, WISC-III-NL, WAIS-IV-NL); motor outcome used the MABC-2 checklist and parent/medical-chart data on motor milestones and physical therapy.
- Linear mixed models with a random intercept for family compared endocrine status groups (MPHD, isolated central CH, healthy siblings), followed by post hoc Tukey tests; pretreatment and assessment-time FT4 were added to FSIQ models.
Limitations
- The paper states that the MABC-2 checklist was suitable only for part of the patients, yielding a relatively small motor-outcome group, and that a checklist is less reliable than objective motor assessment; it also states that excluding syndromic patients leaves cognitive outcome in syndromic patients unexplored.
- The paper states that the study cannot answer whether neonatal screening for central CH prevents cognitive impairment, because late-detected patients were not studied.
- Evident from the text: assessors were not formally blinded to disease status, and 35 eligible patients declined participation, which may introduce selection bias despite the nationwide cohort.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
27 of 48 cited sources checked · 15 supported · 0 flagged · accuracy not yet measured
- Premisecitation
In a recent systematic review, sufficiently large studies on cognitive outcome in patients with central congenital hypothyroidism are lacking.
“In a recent systematic review, we showed that sufficiently large studies on cognitive outcome in patients with central CH are lacking (14).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Naafs, 2020, Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data, Eur J Endocrinol. source
The passages available from our copy identify the paper as a systematic review of cognitive outcome in congenital central hypothyroidism, but contain no findings about the size of existing studies. Searches for the claimed lack of sufficiently large studies and for small sample sizes found no passage addressing that conclusion. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Premisecitation
Clinical detection of central congenital hypothyroidism usually occurs far beyond the neonatal period.
“clinical detection usually occurs far beyond the neonatal period (8-10).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [8] Zwaveling-Soonawala, 2015, The severity of congenital hypothyroidism of central origin should not be underestimated, J Clin Endocrinol Metab source
The Discussion (page not available) reports a cohort of 34 children with late-diagnosed central congenital hypothyroidism, supporting that clinical diagnosis can be delayed. It does not give their ages at diagnosis or establish that detection usually occurs far beyond the neonatal period. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [9] Nebesio, 2010, Newborn screening results in children with central hypothyroidism, J Pediatr. source
- cites [10] Cavarzere, 2014, Diagnostic pitfalls in the assessment of congenital hypopituitarism, J Endocrinol Invest. source
- Premisecitation
Multiple pituitary hormone deficiencies are present in the majority of patients with central congenital hypothyroidism.
“MPHD are present in the majority of patients with central CH (7).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [7] van Tijn, 2005, Neonatal detection of congenital hypothyroidism of central origin, J Clin Endocrinol Metab. source
- Premisecitation
Patients with multiple pituitary hormone deficiencies are at risk for severe hypoglycemia and thus for brain damage and cognitive impairment.
“With these hormone deficiencies, patients with MPHD are at risk for severe hypoglycemia and thus for brain damage and cognitive impairment (12, 13).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [12] Harding, 2017, An emerging evidence base for the management of neonatal hypoglycaemia, Early Hum Dev. source
The Outcomes section states that severe, persistent hypoglycaemia can cause brain injury in newborns and discusses possible later neurocognitive impairment. It does not identify patients with multiple pituitary hormone deficiencies as a group at risk for hypoglycaemia, so the claim's MPHD-specific part is unsupported. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [13] McKinlay, 2017, Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years, JAMA Pediatr. source
- Premisecitation
More than half of patients with central congenital hypothyroidism have moderate to severe hypothyroidism.
“more than half of patients with central CH have moderate to severe hypothyroidism”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [8] Zwaveling-Soonawala, 2015, The severity of congenital hypothyroidism of central origin should not be underestimated, J Clin Endocrinol Metab source
- cites [9] Nebesio, 2010, Newborn screening results in children with central hypothyroidism, J Pediatr. source
- cites [10] Cavarzere, 2014, Diagnostic pitfalls in the assessment of congenital hypopituitarism, J Endocrinol Invest. source
- Premisecitation
In that previous study, 95% of patients with early-detected central congenital hypothyroidism were diagnosed only after notification of an abnormal neonatal screening result.
“Instead, 95% were diagnosed only after the notification of an abnormal neonatal screening result.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Naafs, 2020, Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening, Eur J Endocrinol. source
The Early signs and symptoms section reports that 61 patients were hospitalized before screening results were known; among those patients, 95% were diagnosed only after the results were reported. The claim omits that hospitalized-subgroup qualifier and presents 95% as applying to all early-detected patients. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
When treated early, the cognitive outcome of children with primary congenital hypothyroidism improves substantially.
“When treated early, the cognitive outcome of children with primary CH improves substantially.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [2] Aleksander, 2018, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism, J Clin Endocrinol Metab. source
- cites [3] Albert, 2013, Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring, J Clin Endocrinol Metab. source
- Premisecitation
Previous studies in patients with primary congenital hypothyroidism have shown a relationship between pretreatment (F)T4 and FSIQ or obtained educational level.
“Previous studies in patients with primary CH have shown a relationship between pretreatment (F)T4, and FSIQ or obtained educational level (23-25).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [23] Kooistra, 1994, Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment, J Pediatr. source
- cites [24] Kempers, 2006, Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening, J Clin Endocrinol Metab source
- cites [25] Seo, 2017, Intellectual development in preschool children with early treated congenital hypothyroidism, Ann Pediatr Endocrinol Metab. source
- Findingown data
Patients with multiple pituitary hormone deficiencies scored 7.5 points lower on full-scale intelligence quotient than patients with isolated central congenital hypothyroidism (95% CI -15.1 to 0.01, P = .05).
“Post hoc analysis showed that patients with MPHD scored 7.9 points lower than siblings (95% CI –13.4 to –2.5, P = .002), and 7.5 points lower than patients with isolated central CH (95% CI –15.1 to 0.01, P = .05; Table 4).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
In patients with early-detected central congenital hypothyroidism, those with multiple pituitary hormone deficiencies have a significantly lower full-scale IQ than siblings.
“we show a normal FSIQ in patients with isolated central CH, but a significantly lower FSIQ in patients with MPHD than in siblings.”
- Also stated in: § Cognitive outcome · plain
“MPHD vs siblings | –7.9 | 2.3 | –13.4 | –2.5 | .002”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Also stated in: § Cognitive outcome · plain
- Findingown data
Processing speed was lower in both patient groups than in siblings (mean differences -10.5 and -10.3 points).
“Processing speed was lower in both patient groups than in siblings (mean differences –10.5 and –10.3 points).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Motor difficulties occurred significantly more often in patients (33%) than in siblings (5%; P = .004).
“Motor difficulties occurred significantly more often in patients (33%) versus siblings (5%; P = .004).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Findingown data
Patients with multiple pituitary hormone deficiencies had lower pretreatment free thyroxine than patients with isolated central congenital hypothyroidism.
“Pretreatment FT4 (pmol/L) | 8.8 ± 2.0 | 10.4 ± 2.3 | <.001”
Quote in the paperNot a substantial claim- Rests on an assumption: The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
- Findingown data
Delayed motor development requiring physical therapy was present in 30 patients (34%) and 10 siblings (19%; P = .03).
“In addition, delayed motor development requiring physical therapy was present in 30 patients (34%) and 10 siblings (19%; P = .03).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Findingown data
The later age at walking independently in patients compared with siblings was mainly due to the difference between patients with multiple pituitary hormone deficiencies and siblings.
“Milestone “walking independently” was reached significantly later by patients than siblings; this age difference was mainly caused by the difference between patients with MPHD and siblings (Table 4).”
Quote in the paperNot a substantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Rests on an assumption: Missing motor milestone data are missing at random, so available motor milestone data are representative.
- Findingown data
Among patients with central congenital hypothyroidism, pretreatment FT4 concentration has a weak positive correlation with processing speed (r = 0.22; P = .04).
“Among patients, a weak correlation between pretreatment FT4 and processing speed was seen (r = 0.22; P = .04).”
Quote in the paperNot a substantial claim - Findingown data
Patients with multiple pituitary hormone deficiencies scored 7.9 points lower on full-scale intelligence quotient than siblings (95% CI -13.4 to -2.5, P = .002).
“Post hoc analysis showed that patients with MPHD scored 7.9 points lower than siblings (95% CI –13.4 to –2.5, P = .002), and 7.5 points lower than patients with isolated central CH (95% CI –15.1 to 0.01, P = .05; Table 4).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Mean full-scale intelligence quotient in siblings was 98.6 (95% CI 94.5-102.8).
“Mean FSIQ in patients with MPHD was 90.7 (95% CI 86.4-95.0), compared with 98.2 (95% CI 93.0-103.5) in patients with isolated central CH, and 98.6 (95% CI 94.5-102.8) in siblings (Table 3).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Neonatal hypoglycemia occurred more often in patients with multiple pituitary hormone deficiencies (55%) than in patients with isolated central congenital hypothyroidism (15%).
“Neonatal hypoglycemia | 28 (55)(n = 51) | 5 (15)(n = 34) | <.001”
Quote in the paperNot a substantial claim- Rests on an assumption: The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
- Findingown data
Adding pretreatment free thyroxine to the model did not improve the fit of the model (P = .18).
“Adding pretreatment FT4, as indicator of severity of hypothyroidism, to the model did not improve the fit of the model (P = .18).”
Quote in the paperNot a substantial claim - Findingown data
In patients with early-detected central congenital hypothyroidism, those with isolated central congenital hypothyroidism have a normal full-scale IQ compared with siblings.
“we show a normal FSIQ in patients with isolated central CH, but a significantly lower FSIQ in patients with MPHD than in siblings.”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Findingown data
Mean full-scale intelligence quotient in patients with isolated central congenital hypothyroidism was 98.2 (95% CI 93.0-103.5).
“Mean FSIQ in patients with MPHD was 90.7 (95% CI 86.4-95.0), compared with 98.2 (95% CI 93.0-103.5) in patients with isolated central CH, and 98.6 (95% CI 94.5-102.8) in siblings (Table 3).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Among patients with multiple pituitary hormone deficiencies in special education, pairwise analysis showed no significant difference in special education attendance between patients and their participating siblings (P = .68).
“Only 6 out of 9 patients with MPHD in special education had a participating sibling; pairwise analysis showed no significant difference between patients and siblings (P = .68).”
Quote in the paperNot a substantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Findingown data
In patients with central congenital hypothyroidism, an FSIQ <85 (< -1 SD) was seen in 28 (32%) patients versus 8 (15%) siblings (P = .05).
“An FSIQ <85, that is, <–1 SD in the general population, was seen in 28 (32%) patients versus 8 (15%) siblings (P = .05).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Findingown data
Adding the free thyroxine concentration measured at the time of assessment to the model for full-scale intelligence quotient did not improve the model fit (P = .88).
“Adding the FT4 concentration measured at the time of the assessment to the model for FSIQ did not improve the model fit (P = .88).”
Quote in the paperNot a substantial claim - Findingown data
Comparisons of primary and secondary outcomes between groups did not change when patients with a FT4 concentration outside the target range during the cognitive assessment were excluded.
“Comparisons of primary and secondary outcomes between groups did not change when patients with a FT4 concentration outside the target range during the cognitive assessment were excluded.”
Quote in the paperNot a substantial claim - Findingown data
Mean full-scale intelligence quotient in patients with multiple pituitary hormone deficiencies was 90.7 (95% CI 86.4-95.0).
“Mean FSIQ in patients with MPHD was 90.7 (95% CI 86.4-95.0), compared with 98.2 (95% CI 93.0-103.5) in patients with isolated central CH, and 98.6 (95% CI 94.5-102.8) in siblings (Table 3).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Patients with multiple pituitary hormone deficiencies attended special education more frequently than patients with isolated central congenital hypothyroidism (9/52 vs 1/35, P = .04).
“Patients with MPHD attended special education more frequently than patients with isolated central CH (9/52 vs 1/35, P = .04).”
Quote in the paperSubstantial claim - Findingown data
Patients with isolated central congenital hypothyroidism did not score lower on full-scale intelligence quotient than siblings.
“While patients with MPHD scored lower FSIQs than siblings (mean difference –7.9 points, 95% CI –13.4 to –2.5; P = .002), patients with isolated central CH did not.”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Findingown data
Ten patients (11%) and 4 siblings (8%) attended special education.
“Ten patients (11%) and 4 siblings (8%) attended special education.”
Quote in the paperNot a substantial claim - Findingown data
Neonatal hypoglycemia was frequently documented in patients with multiple pituitary hormone deficiencies (see Table 2).
“Untreated growth hormone deficiency and central adrenal insufficiency can cause neonatal hypoglycemia which was indeed frequently documented (see Table 2).”
Quote in the paperSubstantial claim - Findingown data
Pretreatment FT4 concentration was not significantly associated with FSIQ in the linear mixed model.
“However, pretreatment FT4 concentration was not significantly associated with FSIQ in the linear mixed model.”
Quote in the paperSubstantial claim - Premisecitation
Early treatment of primary congenital hypothyroidism prevents irreversible brain damage.
“Since early treatment of children with congenital hypothyroidism (CH) prevents irreversible brain damage (1)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Klein, 1972, Improved prognosis in congenital hypothyroidism treated before age three months, J Pediatr. source
- Premisecitation
Thyroxine-binding globulin measurement prevents false-positive results due to thyroxine-binding globulin deficiency.
“TBG measurement prevents false-positive results due to TBG deficiency (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Lanting, 2005, Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program, Pediatrics. source
- Premisecitation
The Dutch neonatal screening approach effectively detects primary and central congenital hypothyroidism.
“This approach effectively detects primary and central CH.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Lanting, 2005, Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program, Pediatrics. source
- Study design and conductcitation
Female siblings with TBL1X or IRS4 variants (carriers) were excluded from the sibling control group.
“Whereas male patients with isolated central CH caused by (X-linked) TBL1X or IRS4 variants were included, female siblings with these variants, namely carriers, were not.”
Quote in the paperSubstantial claim - Interpretationreasoning
The lower full-scale intelligence quotient in patients with multiple pituitary hormone deficiencies may be explained by disease-specific consequences of multiple pituitary hormone deficiencies, such as neonatal hypoglycemia and more severe hypothyroidism.
“This may be explained by disease-specific consequences of MPHD, such as neonatal hypoglycemia and more severe hypothyroidism.”
Quote in the paperSubstantial claim- Rests on an assumption: The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
- Rests on an assumption: Lack of formal blinding of assessors did not materially bias the cognitive assessments.
- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
- Study design and conductown data
Perinatal and sociodemographic characteristics of participants were comparable between patients and siblings.
“Table 1 summarizes the perinatal and sociodemographic characteristics of participants, which were comparable between patients and siblings.”
Quote in the paperSubstantial claim - Premisecitation
Developmental delay in pituitary stalk interruption syndrome has been described in some patients.
“Developmental delay in PSIS has not been studied extensively but has been described in some patients (26, 27).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [26] Vergier, 2019, Diagnosis of endocrine disease: pituitary stalk interruption syndrome: etiology and clinical manifestations, Eur J Endocrinol. source
- cites [27] Azar-Kolakez, 2013, All-cause and disease-specific mortality and morbidity in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study, J Clin Endocrinol Metab. source
- Premisecitation
Untreated growth hormone deficiency and central adrenal insufficiency can cause neonatal hypoglycemia.
“Untreated growth hormone deficiency and central adrenal insufficiency can cause neonatal hypoglycemia which was indeed frequently documented (see Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] McKinlay, 2017, Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years, JAMA Pediatr. source
- Interpretationreasoning
Our results suggest that motor function might be affected in a similar way in central congenital hypothyroidism.
“Our results suggest that motor function might be affected in a similar way in central CH.”
Quote in the paperSubstantial claim - Interpretationreasoning
Early detection and treatment likely contributed to the normal FSIQs among patients with isolated central congenital hypothyroidism.
“Whether early detection and treatment contributed to the normal FSIQs among our patients with isolated central CH is likely, but hard to prove with certainty.”
Quote in the paperSubstantial claim - Interpretationown data
The correlation between pretreatment FT4 and processing speed indicates that severity of hypothyroidism affects processing speed.
“The correlation with pretreatment FT4 indicates that severity of hypothyroidism does affect processing speed.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 25
- May combine two claims. 26
- The quote only partly states this claim. 2
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Motor Assessment Battery for Children-2 checklist was developed to screen 5- to 13-year-old children in primary education for motor difficulties.
“Parents were asked to complete the Motor Assessment Battery for Children-2 (MABC-2) checklist, developed to screen 5- to 13-year-old children in primary education for motor difficulties (19).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [19] Schoemaker, 2003, Psychometric properties of the movement assessment battery for children-checklist as a screening instrument for children with a developmental co-ordination disorder, Br J Educ Psychol. source
The Background (p. 2) says the M-ABC Checklist was developed to screen children for movement difficulties in schools. But the instrument described is the original M-ABC Checklist, not the MABC-2 checklist; the paper describes its items as covering children aged 4–12, not 5–13 (p. 3). (LLM, conf=0.90)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationCarriers of TBL1X or IRS4 variants are reported to have lower plasma free thyroxine concentrations, and it remains unclear whether this represents disease or reflects an altered individual set point.
“This is because carriers are reported to have lower plasma FT4 concentrations, and it remains unclear whether this represents disease or reflects an altered individual “set point” (16).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] Heinen, 2016, Mutations in TBL1X are associated with central hypothyroidism, J Clin Endocrinol Metab. source
The Results report lower plasma FT4 concentrations in adults with TBL1X mutations than in controls. The Discussion questions whether the lower concentrations cause hypothyroidism in target tissues and considers individual FT4 set points. These passages support the claim for TBL1X carriers, but not its extension to IRS4 carriers; no page numbers were available in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn those studies, full-scale intelligence quotients were shifted towards lower values, with 10% of patients having an FSIQ below 70.
“FSIQs were shifted towards lower values with 10% of patients having an FSIQ <70 (below –2 SD in the general population)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Naafs, 2020, Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data, Eur J Endocrinol. source
May combine two claims.
PremisecitationThe included studies were small, heterogeneous, and possibly suffered from selection bias, so results should be interpreted with caution.
“but the included studies were small, heterogeneous, and possibly suffered from selection bias, so that results should be interpreted with caution (14).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Naafs, 2020, Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data, Eur J Endocrinol. source
The indexed Abstract passage is a publication record, not a discussion of the included studies. Searches for small studies, heterogeneity, selection bias, and limitations found no passage addressing those points, so the claimed caution cannot be verified from our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn a previous study of patients with early-detected central congenital hypothyroidism, the diagnosis was seldom made based on clinical signs, even though 66% had been hospitalized in the first week of life.
“we found that the diagnosis was seldom made based on clinical signs, even though 66% of these patients had been hospitalized in the first week of life (11).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Naafs, 2020, Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening, Eur J Endocrinol. source
The Results and Early signs and symptoms sections report that 61 of 92 patients (66%) were hospitalized before screening results were known, but only three were diagnosed on clinical grounds during those admissions. Our copy does not establish that all 61 hospitalizations occurred in the first week of life. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIsolated central congenital hypothyroidism is associated with X-linked genes.
“A male predominance was seen among patients; this was not unexpected since isolated central CH is associated with X-linked genes (16, 22).”
Quote in the paperNot a substantial claim2 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe z-test for partially paired samples was used because the MABC-2 checklist is validated for ages 5 to 13 only, rendering a partially paired sample.
“Proportions of abnormal MABC-2 scores were compared using the z-test for partially paired samples, as the MABC-2 checklist is validated for ages 5 to 13 only, thus rendering a partially paired sample (20).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Derrick, 2015, Test statistics for comparing two proportions with partially overlapping samples, J Appl Quant Methods
The Introduction (page not provided) describes comparing proportions when samples contain both paired and unpaired observations, and the Additional information section recommends a z-statistic for that setting. The paper does not address the MABC-2 checklist, its validated age range, or whether that age range made the citing study's samples partially paired. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe majority of early-treated patients with primary congenital hypothyroidism now obtain normal or near-normal IQ scores.
“the majority of early-treated patients now obtain normal or near-normal IQ scores (2, 3).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [2] Aleksander, 2018, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism, J Clin Endocrinol Metab. source
- cites [3] Albert, 2013, Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring, J Clin Endocrinol Metab. source
May combine two claims.
PremisecitationIn a previous study, 96% of patients with multiple pituitary hormone deficiencies had growth hormone deficiency and 88% had central adrenal insufficiency.
“In our previous study 96% of patients with MPHD had growth hormone deficiency, and 88% had central adrenal insufficiency (11).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Naafs, 2020, Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening, Eur J Endocrinol. source
The Discussion reports that 96% of MPHD patients had growth hormone deficiency. It reports ACTH deficiency—the relevant measure for central adrenal insufficiency—in 49 of 57 MPHD patients (86%), not 88%. The paper’s 88% figure refers to patients hospitalized before neonatal screening results became known. (LLM, conf=0.92)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe systematic review identified 6 studies measuring full-scale intelligence quotient, including 30 patients in total (27/30 with multiple pituitary hormone deficiencies).
“We identified 6 studies that measured full-scale intelligence quotient (FSIQ), including 30 patients in total (27/30 MPHD).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Naafs, 2020, Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data, Eur J Endocrinol. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA lower processing speed has also been reported in patients with early-detected primary congenital hypothyroidism, although not consistently.
“A lower processing speed has also been reported in patients with early-detected primary CH, although not consistently (2, 31).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [2] Aleksander, 2018, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism, J Clin Endocrinol Metab. source
- cites [31] Pardo Campos, 2017, Cognitive profiles of patients with early detected and treated congenital hypothyroidism, Arch Argent Pediatr. source
The Results report lower processing speed in children whose congenital hypothyroidism was diagnosed and treated before 30 days of age, compared with children without it. The cited paper does not establish the sentence’s additional qualification that this finding has been reported inconsistently. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationJoustra et al. examined executive functioning and memory, but not FSIQ, in 15 adult patients with IGSF1 deficiency syndrome; patients performed worse than controls on executive functioning tasks, while their memory function was normal.
“In addition, Joustra et al. examined executive functioning and memory, but not FSIQ, in 15 adult patients with IGSF1 deficiency syndrome. Patients performed worse than controls on executive functioning tasks, while their memory function was normal (29).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Joustra, 2016, Mild deficits in attentional control in patients with the IGSF1 deficiency syndrome, Clin Endocrinol (Oxf). source
May combine two claims.
PremisecitationSo far, FSIQ has only been reported in a few patients with isolated central congenital hypothyroidism; in the authors' previous systematic review, patients with isolated central congenital hypothyroidism were underrepresented.
“So far, FSIQ has only been reported in a few patients with isolated central CH; in our previous systematic review patients with isolated central CH were underrepresented, highlighting the need for further studies on cognitive outcome in this condition (14, 28).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [14] Naafs, 2020, Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data, Eur J Endocrinol. source
- cites [28] Karges, 2004, Compound heterozygous and homozygous mutations of the TSHbeta gene as a cause of congenital central hypothyroidism in Europe, Horm Res. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn general, cognitive outcomes are normal in patients with early-treated mild or moderate primary congenital hypothyroidism, while developmental problems may occur in patients with severe primary congenital hypothyroidism despite early treatment.
“In general, cognitive outcomes are normal in patients with early-treated mild or moderate primary CH while developmental problems may occur in patients with severe primary CH, despite early treatment (2, 3, 6, 24).”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [2] Aleksander, 2018, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism, J Clin Endocrinol Metab. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [3] Albert, 2013, Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring, J Clin Endocrinol Metab. source
- cites [6] Léger, 2014, European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism, Horm Res Paediatr. source
- cites [24] Kempers, 2006, Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening, J Clin Endocrinol Metab source
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationA male predominance was seen among patients.
“A male predominance was seen among patients; this was not unexpected since isolated central CH is associated with X-linked genes (16, 22).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFree thyroxine concentration was within target range in 80 patients (92%), above the upper limit of the reference interval in 5 patients, and below the lower limit in 2 patients.
“FT4 concentration was within target range in 80 patients (92%), above the upper limit of the reference interval in 5 patients (23-25.9 pmol/L) and below the lower limit in 2 patients (8.4 and 10 pmol/L).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataMotor difficulties, as indicated by the MABC-2 checklist, were present more often in patients with central congenital hypothyroidism than in siblings (P = .004).
“Motor difficulties were seen more often in patients than in siblings (P = .004).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
May combine two claims.
Findingown dataIn patients with central congenital hypothyroidism, an FSIQ <70 (< -2 SD) was seen in 8 patients (9%), but no sibling controls (P = .04).
“Eight patients (9%), but no sibling controls, had an FSIQ <70, <–2 SD in the general population (P = .04).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
May combine two claims.
Findingown dataIn patients with early-treated isolated central congenital hypothyroidism, verbal IQ and performance IQ were similar to siblings.
“FSIQ, verbal IQ, and performance IQ in patients with early-treated isolated central CH were similar to siblings.”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA weak positive correlation between pretreatment free thyroxine and full-scale intelligence quotient was found (r = 0.22; P = .04).
“If assessed outside of the model, a weak positive correlation between pretreatment FT4 and FSIQ was found (r = 0.22; P = .04).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataThe milestone of walking independently was reached significantly later by patients with central congenital hypothyroidism than by siblings.
“Milestone “walking independently” was reached significantly later by patients than siblings; this age difference was mainly caused by the difference between patients with MPHD and siblings (Table 4).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
- Rests on an assumption: Missing motor milestone data are missing at random, so available motor milestone data are representative.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFSIQ and additional subscales did not differ between patients with and without a participating sibling (data not shown).
“FSIQ and additional subscales did not differ between patients with and without a participating sibling (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataProcessing speed is significantly lower in both isolated central congenital hypothyroidism and multiple pituitary hormone deficiency patients compared with siblings, with similar differences of about 10.3 and 10.5 points lower, respectively.
“Processing speed was significantly lower in both patient groups when compared with siblings, with a similar difference in patients with MPHD and patients with isolated central CH, scoring on average 10.5 and 10.3 points lower than siblings (Table 4).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataGenetic etiology was identified in 27 of 35 patients with isolated central congenital hypothyroidism.
“which includes the genetic etiology of isolated central CH for 27 out of 35 cases (15 IGSF1, 5 IRS4, 5 TBL1X, 1 TRHR, 1 TSHB).”
Quote in the paperNot a substantial claim- Rests on an assumption: The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
May combine two claims.
Findingown dataMean full-scale intelligence quotient was 93.8 ± 17.9 in all patients with central congenital hypothyroidism and 99.2 ± 14.0 in siblings.
“Mean FSIQ was 93.8 ± 17.9 in all patients with central CH and 99.2 ± 14.0 in siblings (Fig. 1).”
Quote in the paperSubstantial claim- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
May combine two claims.
Findingown dataBased on pretreatment FT4 concentration, 69% of patients with multiple pituitary hormone deficiencies had moderate to severe hypothyroidism, compared with 37% of patients with isolated central congenital hypothyroidism.
“Based on the pretreatment FT4 concentration 69% of patients with MPHD had moderate to severe hypothyroidism, opposed to only 37% of patients with isolated central CH.”
Quote in the paperSubstantial claim- Rests on an assumption: Pretreatment FT4 concentration categories (moderate to severe versus mild) reflect the severity of hypothyroidism.
May combine two claims.
Findingnone givenAlmost all patients with multiple pituitary hormone deficiencies had pituitary stalk interruption syndrome, creating a homogeneous group of patients, and almost all patients with isolated central congenital hypothyroidism had a genetically confirmed diagnosis.
“Almost all patients with MPHD had PSIS, creating a homogeneous group of patients, and almost all patients with isolated central CH had a genetically confirmed diagnosis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOnly 6 out of 9 patients with multiple pituitary hormone deficiencies in special education had a participating sibling.
“Only 6 out of 9 patients with MPHD in special education had a participating sibling; pairwise analysis showed no significant difference between patients and siblings (P = .68).”
Quote in the paperNot a substantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
May combine two claims.
Findingown dataThe MABC-2 checklist indicated motor difficulties in 5 patients with isolated central congenital hypothyroidism (33%), 8 patients with multiple pituitary hormone deficiencies (33%), and 1 sibling (5%).
“The MABC-2 checklist was completed for 39 patients (24 MPHD, 15 isolated central CH) and 21 siblings, and indicated motor difficulties in 5 patients with isolated central CH (33%), 8 MPHD patients (33%), and 1 sibling (5%).”
Quote in the paperSubstantial claim- Rests on an assumption: Siblings are an ideal control group for patients with central congenital hypothyroidism.
Classified as probably not a substantial claim.
Study design and conductnone givenBy using a sibling control group, confounding factors shared by patients and siblings were controlled for.
“By using a sibling control group, confounding factors shared by patients and siblings were controlled for.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningSince all tests yielded age-specific norm scores, age was not added to the model.
“Since all tests yielded age-specific norm scores, age was not added to the model.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationWhen a participant underwent a Wechsler test within the previous 12 months (n = 4), the first score was obtained rather than retesting, to prevent an inflated score due to a practice effect.
“When a participant underwent a Wechsler test within the previous 12 months (n = 4), the first score was obtained rather than retesting, to prevent an inflated score due to a practice effect (18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Sirois, 2002, Quantifying practice effects in longitudinal research with the WISC-R and WAIS-R: a study of children and adolescents with hemophilia and male siblings without hemophilia, J Pediatr Psychol. source
May combine two claims.
PremisecitationThe Dutch neonatal screening program since 1995 uses a 3-step approach with T4 measurement first, TSH measurement in the lowest 20% of T4 concentrations, and TBG measurement in the lowest 5%.
“Since 1995, the Dutch neonatal screening program has consisted of a 3-step approach, with T4 measurement as the first step in all neonates, TSH measurement in the lowest 20% of T4 concentrations, and thyroxine-binding globulin (TBG) measurement in the lowest 5%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Lanting, 2005, Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program, Pediatrics. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAssessors were not formally blinded for participants' disease status.
“Although assessors were not involved in clinical care for the patients, they were not formally blinded for the participants’ disease status: participants were not asked to conceal their disease status but were also not encouraged to talk about it.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenA linear mixed model accounts for the fact that patient and sibling data are not independent, and facilitates the use of data from all patients, regardless of the presence of an eligible sibling.
“A linear mixed model accounts for the fact that patient and sibling data are not independent, and facilitates the use of data from all patients, regardless of the presence of an eligible sibling.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationThe end date ensured patients would be at least 3 years old, which is considered the youngest age to reliably conduct the selected intelligence tests.
“The end date ensured patients would be ≥3 years old, which is considered the youngest age to reliably conduct the selected intelligence tests (15).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Baron, 2012, Assessment of intelligence in the preschool period, Neuropsychol Rev source
May combine two claims.
Interpretationown dataIn early-treated central congenital hypothyroidism, full-scale intelligence quotient is comparable with siblings in patients with isolated central congenital hypothyroidism, while patients with multiple pituitary hormone deficiencies have a significantly lower full-scale intelligence quotient.
“In early-treated central CH, FSIQ is comparable with siblings in patients with isolated central CH, while patients with MPHD have a significantly lower FSIQ.”
Quote in the paperSubstantial claim- Rests on an assumption: The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
- Rests on an assumption: Lack of formal blinding of assessors did not materially bias the cognitive assessments.
- Rests on an assumption: The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
- Rests on an assumption: The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
Probably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenThe use of a checklist is considered less reliable than an objective motor assessment.
“In addition, the use of a checklist is considered less reliable than an objective motor assessment.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationEarly postnatal hypothyroidism affects cerebellar development, and this mechanism is thought to be the origin of motor deficits in primary congenital hypothyroidism.
“Early postnatal hypothyroidism affects cerebellar development, and this mechanism is thought to be the origin of motor deficits in primary CH (32).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Zoeller, 2004, Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings, J Neuroendocrinol. source
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningIt is likely that neonatal screening prevents prolonged thyroid hormone shortage and its consequences on brain development.
“It remains unknown what these outcomes would be without neonatal detection, but it is likely that neonatal screening prevents prolonged thyroid hormone shortage and its consequences on brain development.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenBy using a nationwide cohort, selection bias was minimized compared to a single center study.
“By using a nationwide cohort, selection bias was minimized compared to a single center study, and the included siblings represent an ideal control group.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningThe checklist used to assess motor outcome was only suitable for a part of the patients, leading to a relatively small group for whom motor outcome could be reported.
“A limitation of our study was that the checklist used to assess motor outcome was only suitable for a part of the patients. This led to a relatively small group for whom motor outcome could be reported.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningThe exclusion of syndromic patients from cognitive testing creates a more homogeneous patient group and rules out syndromes as a cause of cognitive impairment, but leaves cognitive outcome in syndromic patients unexplored.
“The exclusion of syndromic patients from cognitive testing can be considered both a strength and a limitation. While this creates a more homogeneous patient group, and rules out syndromes as a cause of cognitive impairment, it leaves cognitive outcome in syndromic patients unexplored.”
Quote in the paperSubstantial claim- Rests on an assumption: The exclusion of syndromic patients from cognitive testing does not bias the cognitive results for the non-syndromic population.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study presents cognitive testing results of the largest group of patients with central congenital hypothyroidism studied to date.
“We present cognitive testing results of the largest group of patients with central CH studied to date.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTo date, central congenital hypothyroidism is the only pituitary hormone deficiency accessible for neonatal screening, which can be performed cost-effectively.
“To date, central CH is the only pituitary hormone deficiency accessible for neonatal screening, which can be performed cost-effectively (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Lanting, 2005, Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program, Pediatrics. source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningIn patients with multiple pituitary hormone deficiencies, early diagnosis prevents the consequences of additional pituitary hormone deficiencies, such as ongoing hypoglycemia, and thus aggravation of cognitive impairment.
“In patients with MPHD, early diagnosis also prevents the consequences of additional pituitary hormone deficiencies, such as ongoing hypoglycemia, and thus aggravation of cognitive impairment.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The included patients are representative of all patients with early-detected central congenital hypothyroidism in the Netherlands.
“From the nationwide database, 133 patients with central CH were identified, of whom 7 were excluded because of a severe syndrome (11). Of the remaining patients, 3 had emigrated, 1 was untraceable, and 35 declined participation in the cognitive assessment, yielding 87 patients and 52 siblings, originating from 84 families.”
The paper relies on this without support.
Lack of formal blinding of assessors did not materially bias the cognitive assessments.
“Although assessors were not involved in clinical care for the patients, they were not formally blinded for the participants’ disease status: participants were not asked to conceal their disease status but were also not encouraged to talk about it.”
The paper relies on this without support.
The included sibling controls were unaffected by central congenital hypothyroidism or other conditions that affect cognitive or motor outcome.
“For each included patient 1 unaffected sibling of at least 3 years old, sharing both biological parents with the patient, was included as control.”
The paper relies on this without support.
The Dutch neonatal screening program detects all or nearly all central congenital hypothyroidism cases in the Netherlands.
“All patients with central CH detected by neonatal screening in The Netherlands are registered in a national database maintained by the Netherlands Organization for Applied Scientific Research.”
The paper relies on this without support.
The different Dutch Wechsler intelligence scales used across age groups yield comparable full-scale intelligence quotient scores.
“We used the most recent Dutch Wechsler scales available at the start of the study: the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III-NL) for participants <6 years, the Wechsler Intelligence Scale for Children (WISC-III-NL) for participants 6 to 16.9 years old, and the Wechsler Adult Intelligence Scale (WAIS-IV-NL) for participants ≥17 years.”
The paper relies on this without support.
Siblings are an ideal control group for patients with central congenital hypothyroidism.
“and the included siblings represent an ideal control group.”
The paper relies on this without support.
Pretreatment FT4 concentration categories (moderate to severe versus mild) reflect the severity of hypothyroidism.
“Based on the pretreatment FT4 concentration 69% of patients with MPHD had moderate to severe hypothyroidism, opposed to only 37% of patients with isolated central CH.”
The paper relies on this without support.
Missing motor milestone data are missing at random, so available motor milestone data are representative.
“Because not all parents could remember when motor milestones were reached, data on motor milestones are not available for all patients.”
The paper relies on this without support.
The exclusion of syndromic patients from cognitive testing does not bias the cognitive results for the non-syndromic population.
“The exclusion of syndromic patients from cognitive testing can be considered both a strength and a limitation.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting upper confidence limit for the MPHD-isolated CH IQ difference
MinorThe prose reports the upper limit of the 95% confidence interval as 0.01, while Table 4 reports 0.02 for the same comparison.
“7.5 points lower than patients with isolated central CH (95% CI –15.1 to 0.01, P = .05; Table 4)”
“| MPHD vs isolated central CH | –7.5 | 3.2 | –15.1 | 0.02 | .05 |”
Cites
Fitting Linear Mixed-Effects Models Using <b>lme4</b>
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835 · see citing works
Fitting Linear Mixed-Effects Models Using lme4Preprint
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435 · see citing works
Zoeller, R. T., & Rovet, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01243.x · Cited by 605 · see citing works
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569 · see citing works
Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years
McKinlay, C. J. D., Alsweiler, J. M., Anstice, N. S., Burakevych, N., Chakraborty, A., Chase, J. G., Gamble, G. D., Harris, D. L., Jacobs, R. J., Jiang, Y., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.1579 · Cited by 395 · see citing works
Improved prognosis in congenital bypothyroidism treated before age three months
Klein, A. H., Meltzer, S., & Kenny, F. M. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80542-0 · Cited by 323 · see citing works
Screening for congenital hypothyroidism: A worldwide view of strategies
Ford, G., & LaFranchi, S. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.008 · Cited by 274 · cited 2× · see citing works
“While it fulfills the criteria for disease screening, central CH is only rarely included in neonatal screening programs (4, 6).”
BackgroundLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208 · see citing works
Kooistra, L., Laane, C., Vulsma, T., Schellekens, J. M. H., van der Meere, J. J., & Kalverboer, A. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83178-6 · Cited by 185 · see citing works
Neonatal Detection of Congenital Hypothyroidism of Central Origin
van Tijn, D. A., de Vijlder, J. J. M., Verbeeten, B., Verkerk, P. H., & Vulsma, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2444 · Cited by 139 · see citing works
Self-citationAn emerging evidence base for the management of neonatal hypoglycaemia
Harding, J. E., Harris, D. L., Hegarty, J. E., Alsweiler, J. M., & McKinlay, C. J. (2017) · Early Human Development · doi:10.1016/j.earlhumdev.2016.12.009 · Cited by 138 · see citing works
Kempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, M. W. G., Kooistra, L., Wiedijk, B. M., Faber, I., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1209 · Cited by 122 · see citing works
Lanting, C. I., van Tijn, D. A., Loeber, J. G., Vulsma, T., de Vijlder, J. J. M., & Verkerk, P. H. (2005) · Pediatrics · doi:10.1542/peds.2004-2162 · Cited by 97 · see citing works
Self-citationVergier, J., Castinetti, F., Saveanu, A., Girard, N., Brue, T., & Reynaud, R. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0168 · Cited by 94 · see citing works
Mutations in <i>TBL1X</i> Are Associated With Central Hypothyroidism
Heinen, C. A., Losekoot, M., Sun, Y., Watson, P. J., Fairall, L., Joustra, S. D., Zwaveling-Soonawala, N., Oostdijk, W., van den Akker, E. L. T., Alders, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2531 · Cited by 92 · see citing works
Self-citationSchoemaker, M. M., Smits‐Engelsman, B. C. M., & Jongmans, M. J. (2003) · British Journal of Educational Psychology · doi:10.1348/000709903322275911 · Cited by 81 · see citing works
Albert, B. B., Heather, N., Derraik, J. G. B., Cutfield, W. S., Wouldes, T., Tregurtha, S., Mathai, S., Webster, D., Jefferies, C., Gunn, A. J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1903 · Cited by 75 · see citing works
Newborn Screening Results in Children with Central Hypothyroidism
Nebesio, T. D., McKenna, M. P., Nabhan, Z. M., & Eugster, E. A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.011 · Cited by 70 · see citing works
Aleksander, P. E., Brückner-Spieler, M., Stoehr, A.-M., Lankes, E., Kühnen, P., Schnabel, D., Ernert, A., Stäblein, W., Craig, M. E., Blankenstein, O., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01937 · Cited by 64 · see citing works
The Severity of Congenital Hypothyroidism of Central Origin Should Not Be Underestimated
Zwaveling-Soonawala, N., van Trotsenburg, A. S. P., & Verkerk, P. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2871 · Cited by 49 · see citing works
Self-citation(2015) · UWE Research Repository (UWE Bristol) · Cited by 39 · see citing works
Mutations in IRS4 are associated with central hypothyroidism
Heinen, C. A., de Vries, E. M., Alders, M., Bikker, H., Zwaveling-Soonawala, N., van den Akker, E. L. T., Bakker, B., Hoorweg-Nijman, G., Roelfsema, F., Hennekam, R. C., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105113 · Cited by 38 · see citing works
Self-citationNaafs, J. C., Verkerk, P. H., Fliers, E., van Trotsenburg, A. S. P., & Zwaveling-Soonawala, N. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0833 · Cited by 35 · see citing works
Self-citationKarges, B., LeHeup, B., Schoenle, E., Castro-Correia, C., Fontoura, M., Pfäffle, R., Andler, W., Debatin, K.-M., & Karges, W. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080071 · Cited by 32 · see citing works
Azar-Kolakez, A., Ecosse, E., Dos Santos, S., & Léger, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2731 · Cited by 27 · see citing works
Assessment of intelligence in the preschool period
Baron, I. S., & Leonberger, K. A. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9215-0 · Cited by 27 · see citing works
Intellectual development in preschool children with early treated congenital hypothyroidism
Seo, M. K., Yoon, J. S., So, C. H., Lee, H. S., & Hwang, J. S. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.2.102 · Cited by 25 · see citing works
Cognitive profiles of patients with early detected and treated congenital hypothyroidism
(2017) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2017.eng.12 · Cited by 25 · see citing works
Naafs, J. C., Vendrig, L. M., Limpens, J., van der Lee, H. J., Duijnhoven, R. G., Marchal, J. P., Trotsenburg, A. S. V., & Zwaveling-Soonawala, N. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0874 · Cited by 24 · see citing works
Self-citationMild deficits in attentional control in patients with the <scp>IGSF</scp>1 deficiency syndrome
Joustra, S. D., Andela, C. D., Oostdijk, W., van Trotsenburg, A. S. P., Fliers, E., Wit, J. M., Pereira, A. M., Middelkoop, H. A. M., & Biermasz, N. R. (2016) · Clinical Endocrinology · doi:10.1111/cen.12947 · Cited by 21 · see citing works
Self-citationWISC-V and the Personalized Assessment Approach
Holdnack, J. A., Prifitera, A., Weiss, L. G., & Saklofske, D. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-404697-9.00012-1 · Cited by 20 · see citing works
Diagnostic pitfalls in the assessment of congenital hypopituitarism
Cavarzere, P., Biban, P., Gaudino, R., Perlini, S., Sartore, L., Chini, L., Silvagni, D., & Antoniazzi, F. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0139-9 · Cited by 18 · see citing works
Sirois, P. A. (2002) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/27.2.121 · Cited by 17 · see citing works
Webb, E. A., & Dattani, M. (2015) · Paediatrics and Child Health · doi:10.1016/j.paed.2015.03.007 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Still being checked.
- Authors
- Naafs, J. C., Marchal, J. P., Fliers, E., Verkerk, P. H., Luijten, M. A. J., Boelen, A., van Trotsenburg, A. S. P., & Zwaveling-Soonawala, N.
- Affiliations
- Emma Kinderziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
- Netherlands Organisation for Applied Scientific Research (NL)
- Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, department of Pediatric Endocrinology, Amsterdam, The Netherlands
- Corresponding author
- Naafs, Jolanda C
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-12-03
- Volume
- 106
- Issue
- 3
- Pages
- e1231-e1239
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC7947775
- OpenAlex
- W3108258316
- Semantic Scholar
- 0b4e95dad01f36942f218bd6ddbc011ec69d00fa
- Cited by
- 21
- References
- 34
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 4
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- TNO Repository (submittedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Pfizer (WI219179)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- multiple pituitary hormone deficiency, early treatment, full-scale intelligence quotient, cognitive outcomes, motor function, neonatal hypoglycemia, processing speed, sibling comparison, newborn screening
- MeSH terms
- Motor Disorders, Adolescent, Child, Child, Preschool, Cognition, Cognition Disorders, Congenital Hypothyroidism, Cross-Sectional Studies, Female, Humans, Infant, Newborn, Intelligence Tests, Male, Motor Activity, Netherlands, Prognosis, Retrospective Studies, Thyroxine, Neonatal Screening, Treatment Outcome, Hormone Replacement Therapy, Siblings, Early Diagnosis, Early Medical Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-27.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-27.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review